|    Join     |    Donate    |   Store    |   About NAMS

Meeting Webcast

NAMS 2013 Meeting Webcast—We’ve Got You Covered!


If you missed the 2013 NAMS Annual Meeting or Pre-Meeting—or if you attended but would like to revisit some of the lectures—you’re in luck! NAMS is pleased to provide a free comprehensive webcast available to all through October 31, 2014. The webcast captures all plenary symposia, keynote address, endowed lectures, and the Pre-Meeting Symposium.

As an added benefit, the webcast from the Pre-Meeting Symposium also will offer continuing education credit to those who were unable to attend the live event.

Please read through the CME information and click the link at the bottom of the page to go to the webcast of the Pre-Meeting and Annual Meeting.

Pre-Meeting Symposium Continuing Education Activity
Vulvovaginal Health: Let’s Talk About It

Free Webcast and CME activity from the Pre-Meeting Symposium at the 2013 Annual Meeting of The North American Menopause Society (NAMS), October 9, 2013

Continuing Medical Education Information

Release Date: October 31, 2013
Expiration Date: October 31, 2014
Estimated Time of Completion: 4 hours

Description

This free archived webcast captures the Pre-Meeting Symposium held in advance of the 24th Annual Meeting of The North American Menopause Society on October 9, 2013. This half-day symposium consisted of seven expert lectures on timely clinical issues regarding vulvovaginal health in women at midlife and beyond, two interactive panel discussions in which the speakers answered audience questions, and case presentations with commentary from the faculty.

Intended Audience

This activity is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare providers who treat or counsel women at midlife and beyond. 

At the conclusion of this activity, participants should be able to:

  • Initiate discussion with patients on vulvovaginal health, including the impact on quality of life and sexuality
  • Perform appropriate clinical assessments to diagnose vulvovaginal conditions
  • List and present a full range of treatment options to patients
  • Collaborate with other healthcare providers to offer effective, individualized therapy for vulvovaginal conditions 
  • Summarize the emerging science of vulvovaginal health, including therapies in the pipeline, and describe its effect on the future of vulvovaginal health care 

Accreditation & Credit Designation

The North American Menopause Society (NAMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMS designates this internet enduring material for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Healthcare professionals who are not physicians who complete this activity will be issued a certificate of participation. They should consult their professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Acknowledgment of Support

This CME activity is supported in part by grant funding from Novo Nordisk Inc., Shionogi Inc., and Warner Chilcott.

Instructions for Participation and Credit

There are no fees for participating in this online educational activity. 

NOTE: Persons who claimed credit for attending the live Pre-Meeting Symposium on which this webcast is based may not claim credit for this webcast activity as well.

To successfully earn credit, participants must follow these steps:

  • Read the information on this page
  • Click “Proceed to the Webcast and CME Activity” below to proceed to the webcast. You may view the entire Pre-Meeting Symposium or proceed through its individual video segments; just be sure to claim only the credit commensurate with your degree of participation.
  • After viewing the webcast content, click “Proceed to Post-Test & Evaluation” at the bottom of the webcast page
  • You will be linked to a PDF form containing a 10-question post-test and activity evaluation. Print this form, fill it out completely, and return the completed form to NAMS by fax (440-442-2660), by mail (see form for address), or by emailing a scan of the form to nams@menopause.org. If you achieve a score of 70% or better on the post-test, NAMS will issue your credit certificate by mail within 30 days. (If you score below 70% on the post-test, you will be given one opportunity to repeat the activity and resubmit your post-test and evaluation.)

Hardware/Software Requirements

To view this activity, users will need:

1) A computer or device with an Internet connection with any of the following installed.

  • Internet Explorer 9 or higher
  • Safari 3 or higher (Mac only)
  • Firefox 21 or higher
  • Chrome 4 or higher

(If you have difficulty viewing the webcast in your default browser or your hardware doesn't support Internet Explorer 9 or higher or Firefox 21 or higher, please try using Chrome 4 or higher as the alternate browser.)

2) Flash Player and/or an HTML5 capable browser may be required for video or audio playback.

For technical assistance or for questions regarding the content of this activity, contact nams@menopause.org.

Disclosures of Moderator, Faculty, Planners, and Staff

This activity has been planned and implemented in accordance with the ACCME’s Essential Areas and Elements, including its Standards for Commercial Support. As a CME provider, NAMS is committed to ensuring independence, balance, and objectivity in its educational activities and has implemented policies and procedures for collecting disclosure information from all faculty and planners involved. NAMS is committed to resolving any conflict, making certain that the activity’s content is aligned with the interests of the public, and is dedicated to implementing safeguards against bias when content is relevant to a commercial interest.

This activity’s moderator, faculty, and planners reported the following relationships that, in the context of their contributions here, could be perceived as a potential conflict of interest:

Dr. BachmannConsultant/Advisory Board: Shionogi, Teva. Dr. Chism—no relevant financial relationships.Dr. Gass—no relevant financial relationships. Dr. GoldsteinConsultant/Advisory Board: Cook ObGyn, Phillips Ultrasound, Shionogi, Warner Chilcott; Speakers' Bureau—Shionogi, Warner Chilcott. Dr. Henderson—no relevant financial relationships. Dr. Herman—no relevant financial relationships. Dr. JoffeAdvisory Board/Review Panel: Noven; Consultant/Contractor: Sunovion; Grant/research support: Teva. Dr. KleinConsultant/Contractor: Pfizer. Dr. KaunitzConsultant/Advisory Board: Agile Therapeutics, Bayer, Merck, Teva; Grants/Research Support: Bayer, Endoceutics, Medical Diagnostic Laboratories, Noven Teva. Dr. KaganConsultant/Advisory Board: Amgen, Depomed, Merck, Noven, Novo Nordisk, Pfizer, Shionogi, Warner Chilcott; Research Grants: Depomed, Merck; Speakers’ Bureau: Novo Nordisk, Noven, Novogyne, Shionogi. Dr. Kronenberg—no relevant financial relationships. Dr. KrychmanConsultant/Advisory Board: Bayer, Palatin, Shionogi, Sprout; Speakers’ Bureau: Bayer, Palatin, Shionogi, Sprout, Warner Chilcott. Dr. MakiConsultant/Advisory Board: Depomed. Dr. Manson—no relevant financial relationships. Dr. Martens—no relevant financial relationships. Dr. Nachtigal—no relevant financial relationships. Dr. Pace—no relevant financial relationships. Dr. Pal—no relevant financial relationships. Dr. PinkertonConsultant/Contractor:DepoMed, Noven, Pfizer, Shionogi; Grant/Research Support: DepoMed, Bionova, Endoceutics; Other: DepoMed, Noven, Pfizer, Shionogi. Dr. Poulin—no relevant financial relationships. Dr. Richardson—no relevant financial relationships. Dr. Schnatz—no relevant financial relationships. Dr. ShapiroConsultant/Advisory Board: Amgen, AstraZeneca, Merck, Novartis, Pfizer; Grants/Research Support:Amgen, Pfizer; Speakers Bureau: Amgen, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi Pasteur, Warner Chilcott. Dr. ShifrenConsultant/Advisory Board: New England Research Institutes. Dr. Shufelt—no relevant financial relationships. Dr. SimonConsultant/Advisory Board:Abbott, Actalis, Agile, Amgen, Ascend, BioSante, Depomed, Merck, Novo Nordisk, Novogyne, Pfizer, Shionogi, Slate, Sprout, Teva, Therapeutics MD, Warner Chilcott; Research Grants: BioSante, Endoceutics, Novo Nordisk, Novogyne, Palatin, Teva, Warner Chilcott;Speakers’ Bureau: Amgen, Merck, Novartis, Novo Nordisk, Novogyne, Teva, Warner Chilcott;Stock/Shareholder: Sprout. Dr. Spitzer—no relevant financial relationships. Dr. Stuenkel—no relevant financial relationships. Dr. Thurston—no relevant financial relationships. Dr. UtianAdvisory Board/Review Panel: Pharmavite, SenoSENSE Inc, Shire, Therapeutics MD

All NAMS staff who could have any influence on the content of this activity reported having no relevant financial relationships to disclose.

Proceed to the Webcast and CME Activity

The contents of this activity are © 2013 The North American Menopause Society. All rights reserved.

Pre-Meeting Symposium

Vulvovaginal Health:
Let's Talk About It

Moderator and Faculty

 

 

 

Risa Kagan, MD, FACOG, CCD, NCMP
Moderator
Department of Obstetrics, Gynecology 
and Reproductive Sciences
University of California, San Francisco
Berkeley, CA

    

Gloria A. Bachmann, MD, NCAS 
Department of Obstetrics, Gynecology, 
and Reproductive Sciences
Rutgers—Robert Wood Johnson Medical School
New Brunswick, NJ

   

Steven R. Goldstein, MD, FACOG, CCD, NCMP 
New York University School of Medicine
New York, NY

   

Hollis Herman, PT, DPT, MS, OCS, WCS, BCB-PMD 
HealthyWomen HealthyMen Physical Therapy
Herman and Wallace Pelvic Rehabilitation Institute
Cambridge, MA

 

   Michael L. Krychman, MDCM 
The Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, CA

 

   

Mark G. Martens, MD, FACOG 
Department of Obstetrics and Gynecology
Jersey Shore University Medical Center
Rutgers—Robert Wood Johnson Medical School
Neptune, NJ

   

James A. Simon, MD, CCD, NCMP, IF, FACOG
George Washington University School of Medicine
Women’s Health and Research Consultants®
Washington, DC

   

Mark Spitzer, MD 
Weill Medical College of Cornell University
Medical Director, Center for Colposcopy
New York, NY

 


Planners

Risa Kagan, MD, FACOG, CCD, NCMP (Chair, 2013 Scientific Program Committee); Diane T. Pace, PhD, FNP-BC, FAANP, NCMP (NAMS President 2012-2013); Cynthia A. Stuenkel, MD, NCMP (Chair, 2012 Scientific Program Committee); JoAnn E. Manson, MD, DrPH, NCMP (Chair, 2014 Scientific Program Committee); Marc J. Poulin, PhD, DPhil (Chair, 2013 Abstract Review Committee); Margery L.S. Gass, MD, NCMP (NAMS Executive Director); Gloria A. Bachmann, MD, NCAS (Chair, 2013 Professional Education Committee); Pauline M. Maki, PhD (Chair, 2013 Research Affairs Committee); Lisa Chism, DNP, APRN, BC, NCMP, FAANP; Steven R. Goldstein, MD, FACOG, CCD, NCMP; Victor W. Henderson, MD, MS; Marjorie R. Jenkins, MD, FACP; Hadine Joffe, MD, MSc; Andrew M. Kaunitz, MD, NCMP; Wendy S. Klein, MD, FACP; Fredi Kronenberg, PhD; Lila E. Nachtigall, MD, NCMP; Lubna Pal, MBBS, MRCOG, MSc, NCMP; JoAnn V. Pinkerton, MD, NCMP; Martha K. Richardson, MD; Peter F. Schnatz, DO, FACOG, FACP, NCMP; Marla Shapiro, MDCM, CCFP, MHSc, FRCP(C), FCFP, NCMP; Jan L. Shifren, MD, NCMP; Chrisandra L. Shufelt, MD, MS, NCMP; James A. Simon, MD, CCD, NCMP, IF, FACOG; Rebecca C. Thurston, PhD; Wulf H. Utian, MD, PhD, DSc (Med)

Copyright© 2014 |  Home  |  Privacy Policy  |   Site Map |
This website is certified by Health On the Net Foundation. Click to verify.

This site complies
with the HONcode
standard
 
for
trustworthy health

information:
verify here.

5900 Landerbrook Drive, Suite 390 - Mayfield Heights, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 4 + 5.